Medication
Medication Summary
See the list below:
-
Atropine has been studied as a potential for conservative management of pyloric stenosis. It is either administered intravenously or orally with the goal of treatment being cessation of projectile vomiting. Success rates vary across studies from 76% to 100% with a mean hospital length of stay of 13 days. [16]
-
The intravenous dose of atropine for treatment of pyloric stenosis ranges in studies from 0.04 to 0.225mg/kg/day and is given for 1 – 10 days.
-
Oral atropine (0.08 – 0.45mg/kg/day) is continued, after IV therapy has been deemed successful, for 3 weeks to 4 months. Predictors of failure are a total of 5 or more projectile vomiting episodes during the first 72 hours of intravenous atropine therapy.
-
Side effects of atropine therapy are rare and include mild facial flushing, raised alanine transaminase and tachycardia. [16]
Media Gallery
-
Point-of-care ultrasound performed by a pediatric emergency physician accurately identifying the pyloric wall thickness and length that meets criteria for pyloric stenosis diagnosis.
-
The ‘antral nipple sign’ demonstrated by the arrow, the ‘X’ indicates the ‘shoulder sign’
-
The ‘donut’ sign demonstrated by the arrow.
-
Lateral view from an upper GI study demonstrates the double-track sign.
of
4
